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were 5.38 times more likely to harbor dual HCMV/EBV infec-
tion than small symptomatic lesions (p = 0.115).  Conclusion: 
Detection of HCMV and EBV in the samples of periapical le-
sions suggests an important role of herpesviruses in periapi-
cal tissue destruction.  © 2015 S. Karger AG, Basel 
 Introduction 
 Periapical lesions are inflammatory immune diseases 
affecting the periapical tissues of the teeth and surround-
ing bone. These processes are primarily caused by poly-
microbial bacterial infection from the root canal, with
a predominance of Gram-negative anaerobic bacteria. 
Their maintenance, progression into chronic lesions and 
destruction of bone structures are the result of the host 
defense’s inability to eliminate the infection  [1, 2] . Peri-
apical lesions are histologically characterized by fibrous 
and granulomatous tissue, proliferating epithelium, or 
cyst infiltrated by various inflammatory cells  [3–6] .
 Although apical periodontitis is generally asymptom-
atic, acute exacerbations occur relatively frequently and 
are associated with the intensification of clinical symp-
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 Abstract 
 Objective: The aim of this study was to investigate the pres-
ence of human cytomegalovirus (HCMV) and Epstein-Barr vi-
rus (EBV) in the tissue of chronic periapical lesions, and to 
compare the results in relation to the symptoms of patients 
and the size of the lesion.  Methods: Periapical lesions ana-
lyzed in the study were collected from the roots of the teeth 
indicated for extraction. Samples were divided according to 
the symptoms into groups of symptomatic and asymptom-
atic, and according the size into groups of small and large 
lesions. Polymerase chain reaction was used to detect HCMV 
and EBV. The amplification was performed in a DNA Thermal 
Cycler (Hybaid).  Results: Symptomatic lesions were 7.68 
times more likely to be infected with HCMV than asymptom-
atic lesions (p < 0.001). Large symptomatic lesions were 
73.50 times more likely to harbor HCMV than small symp-
tomatic lesions (p < 0.001). Large symptomatic lesions were 
7.64 times more likely to be infected with EBV than small 
symptomatic lesions (p = 0.05). Large symptomatic lesions 
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toms  [1, 2] . The role of polymicrobial bacterial flora is 
well known in the pathogenesis of chronic periapical le-
sions. However, studies have also shown the involvement 
of herpesviruses, in particular human cytomegalovirus 
(HCMV) and Epstein-Barr virus (EBV), in periapical le-
sions  [7] . Latent HCMV is present in periodontal macro-
phages and T lymphocytes, while latent EBV is present in 
periodontal B lymphocytes and epithelial cells of infected 
patients  [8, 9] . During acute exacerbations there is a new 
wave of cross-inflammatory cells that can carry latent 
herpesviruses. An inflammatory environment coupled 
with local bacteria can cause the activation of herpesvi-
ruses. Herpesvirus infection may enhance the production 
of proinflammatory cytokines leading to immunosup-
pression and immunomediated periapical tissue destruc-
tion  [10] .
 The molecular method most often used for microbial 
identification is the polymerase chain reaction (PCR) 
method and its variations. The PCR method has been 
used in many investigations to provide additional valu-
able information regarding the identification and under-
standing of the causative factors associated with end-
odontic diseases, and may contribute to the development 
of improved treatment strategies  [11] .
 The aim of this study was to investigate the presence 
of HCMV and EBV in the tissue of periapical lesions us-
ing PCR, and to compare the obtained results in relation 
to the symptoms of patients and the size of the lesion.
 Materials and Methods 
 The study included 60 adult patients (33 males and 27 females; 
age range: 27–58 years, average age: 43) from the Clinic of Den-
tistry, Medical Faculty, University of Nis, Serbia. Each patient had 
a clinically and radiographically diagnosed chronic periapical le-
sion. The study was approved by the Ethical Committee of the 
Medical Faculty, University of Nis, Serbia.
 Periapical lesions analyzed in the study were collected from the 
roots of the teeth indicated for extraction. None of the cases dem-
onstrated a moderate or severe type of marginal periodontitis. 
Periapical lesions were divided according to the symptoms into 
two groups: symptomatic and asymptomatic. Symptoms included 
swelling, pain, biting discomfort, or percussion and palpation sen-
sitivity. According to their size, periapical lesions were divided into 
two groups: small ( ≤ 5 mm) and large ( ≥ 6 mm). In order to estab-
lish the correct sample size, the measuring of the lesions was per-
formed before tooth extraction on the radiographs and again after 
tooth extraction.
 Prior to administration of local anesthetics, the teeth, gingiva 
and surrounding mucosa were washed with 0.12% chlorhexidine 
gluconate, and patients rinsed their mouth with chlorhexidine 
mouthwash for 30 s. The samples of periapical lesions were taken 
immediately after teeth extractions, rinsed in sterile saline solu-
tion, dried on sterile paper, placed in sterile plastic vial and imme-
diately frozen at –70°.
 PCR was used to detect HCMV and EBV. The samples of peri-
apical lesions were unfrozen before PCR analysis. For the purpose 
of DNA extraction, each sample was immersed in 200 μl of physi-
ological buffer with 7 μl of proteinase K. The samples were incu-
bated for 15 min at 55°, and then boiled for 10 min to inactivate 
proteinase K. The material was pelleted by centrifugation and the 
supernatants were transferred into clean tubes and stored at –20° 
until PCR analysis.
 PCR was performed in volumes of 25 μl PCR buffer, 200 μ M of 
each dNTP, 20 n M of primer, 1× buffer (10 m M of KCl and 50 m M 
of Tris-HCl), 3 m M of MgCl, 1.5 U of Taq DNA polymerase and
3 μl of DNA-containing supernatant.
 The amplification was performed in a DNA Thermal Cycler 
(Hybaid).
 Amplification of the HCMV-Specific Gene Sequence 
 Initial denaturation of DNA was performed at 94° for 3 min, 
followed by 30 cycles of denaturation at 94°, annealing at 56° and 
elongation at 72°, 30 s each. Final extension was performed at 72° 
for 5 min.
 Amplification of the EBV-Specific Gene Sequence 
 Initial denaturation of DNA was performed at 94° for 10 min, 
followed by 1 min and 30 s of denaturation at 94°, annealing at 60° 
for 45 s, elongation at 72°, 2 min in 35 cycles. Final extension was 
performed at 72° for 10 min.
 Twenty microliters of amplification mixture were subjected to 
electrophoresis in 8% polyacrylamide gel (20 V/cm in Tris-borate 
EDTA buffer), containing 0.5% μl/ml ethidium bromide. Ampli-
fied fragments were visualized under ultraviolet transilluminator. 
The result was considered to be positive if a band of expected size 
was present. Lymphoid cell lines containing HCMV and EBV were 
used as positive controls, while a PCR mixture containing 3 μl of 
distilled water instead of sample was used as a negative control. 
Details on the sensitivity and specificity of the sets of primers have 
been described previously  [12–14] . Primer sequences and product 
lengths are given in  table 1 .
 Statistical analysis was carried out using the nonparametric χ 2 
test. The likelihood of herpesviruses in symptomatic periapical le-
sions versus asymptomatic and large lesions versus small was ex-
pressed as an odds ratio (OR) and relative risk (RR). Statistical 
significance was set at p < 0.05.
 Results 
 From a total of 60 lesions examined, 31 belonged to the 
symptomatic group (23 large and 8 small) and 29 be-
longed to the group of asymptomatic lesions (18 large and 
11 small).
 Qualitative PCR Outcome 
 A higher occurrence of HCMV infection was present 
in symptomatic lesions compared to asymptomatic. 
PCR analysis showed that 22 of 31 (70.96%) symptom-
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atic lesions, and only 7 of 29 (21.13%) asymptomatic le-
sions were HCMV positive (χ 2 = 13.16; p < 0.001;  ta-
ble 2 ). Analysis with respect to the size showed that 21 
of 23 (91.30%) large symptomatic lesions were HCMV 
positive, while only 1 of 8 (12.5%) small symptomatic 
lesions harbored HCMV (χ 2 = 17.89; p < 0.001;  table 3 ). 
Within the group of asymptomatic lesions, 7 of 18 
(38.88%) large lesions were HCMV positive, whereas all 
small lesions were HCMV negative (χ 2 = 5.64; p < 0.05; 
 table 4 ).
 PCR analysis of EBV showed that 13 of 31 (41.93%) 
symptomatic lesions were EBV positive, and all asymp-
tomatic lesions were EBV negative (χ 2 = 15.53; p < 0.001; 
 table 2 ). In relation to the size, 12 of 23 (52.17%) large 
symptomatic lesions were EBV positive, while 1 of 8 
(12.5%) small symptomatic lesions was EBV positive
(χ 2 = 3.04; p = 0.05;  table 3 ).
 HCMV/EBV dual infection was observed in 11 
(35.48%) of 31 symptomatic lesions, whereas none of 29 
asymptomatic lesions showed dual infection (χ 2 = 12.6;
p < 0.001;  table 2 ). In relation to the size, 10 of 23 (43.48%) 
large symptomatic lesions had dual HCMV/EBV infec-
tion, and 1 of 8 (12.5%) small symptomatic lesions was 
HCMV/EBV positive (χ 2 = 2.49; p = 0.115;  table 3 ).
 Risk Assessment 
 The OR of symptomatic lesions harboring HCMV was 
7.68 times higher than asymptomatic lesions (p < 0.001; 
95% CI: 2.43–24.29;  table 2 ). Large symptomatic lesions 
were 73.50 times more likely to harbor HCMV than small 
symptomatic lesions (p < 0.001; 95% CI: 5.75–939.78). 
Large symptomatic lesions were 7.64 times more likely to 
be infected with EBV than small symptomatic lesions
(p = 0.05; 95% CI: 0.81–72.41). Large symptomatic le-
sions were 5.38 times more likely to harbor dual HCMV/
EBV infection than small symptomatic lesions (p = 0.115; 
95% CI: 0.57–51.17;  table 3 ).
 Discussion 
 Numerous data in the literature refer to the role of her-
pesviruses in the pathogenesis of symptomatic periapical 
pathoses  [15] . Activation of herpesviruses can induce sig-
nificant immunosuppressive and immunomodulating ef-
Target PCR primers Size of amplicon, 
base pairs
HCMV
Forward primer 5′-CCACCCGTGGTGCCAGCTCC-3′ 159
Reverse primer 5′-CCCGCTCCTCCTGAGCACCC-3′
EBV
Forward primer 5′-CTCCCGCACCCTCAACAAGCTA-3′
Reverse primer 5′-GAACCAGAAGGACCCAAAAGCA-3′ 494
 Table 2.  PCR herpesvirus detection in symptomatic and asymp-
tomatic lesions
Herpesvirus Symptomatic
lesions (n = 31)
Asymptomatic
lesions (n = 29)
p OR RR
HCMV 22 (70.96%) 7 (24.13%) <0.001 7.68 2.61
EBV 13 (41.93%) 0 <0.001 – –
HCMV/EBV 11 (35.48%) 0 <0.001 – –
 Table 3.  PCR herpesvirus detection in large and small symptom-
atic lesions
Herpesvirus Large
symptomatic
lesions (n = 23)
Small
symptomatic
lesions (n = 8)
p OR RR
HCMV 21 (91.30%) 1 (12.5%) <0.001 73.50 4.36
EBV 12 (52.17%) 1 (12.5%) 0.05 7.64 1.51
HCMV/EBV 10 (43.48%) 1 (12.5%) 0.115 5.38 1.40
 Table 4.  PCR herpesvirus detection in large and small asymptom-
atic lesions
Herpesvirus Large
asymptomatic
lesions (n = 18)
Small
asymptomatic
lesions (n = 11)
p OR RR
HCMV 7 (38.88%) 0 <0.05 – –
EBV 0 0 – – –
HCMV/EBV 0 0 – – –
 Table 1.  PCR primers for HCMV and EBV
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fects in the periapical area. Observations of active HCMV 
and EBV infections in periapical lesions may help to ex-
plain the different pathological characteristics of these in-
flammatory processes.
 Herpesviruses can cause a series of responses involv-
ing the dysregulation of the host macrophages and lym-
phocytes, which substantially worsen their major role in 
antigen presentation  [16] . This way, they can disrupt the 
antiviral immune response of the host  [17] . HCMV has 
the ability to inhibit the expression of the macrophage 
surface receptors for the lipopolysaccharides, which can 
enhance Gram-negative bacterial infection  [18] . Reacti-
vation of the latent herpesviruses can occur spontaneous-
ly, or during a period of a poor host defense as a result of 
immunosuppression, infection, physical trauma, hor-
monal changes, etc.  [19] . Perhaps not coincidentally, 
many factors that activate herpesviruses are also known 
risk factors for periapical deterioration  [20, 21] . The find-
ings of Sabeti et al.  [22] are consistent with the observa-
tion that various factors of virus activation are risk indica-
tors of acute exacerbation of chronic periapical lesions. 
 In the study by Ozbek and Ozbek  [23] , HCMV DNA 
was found in 22.2% of apical abscess lesions, EBV DNA 
in 11.1%, human papillomavirus DNA in 4.4% and 
HCMV/EBV dual infection in 4% of the lesions. Slots et 
al.  [19] found that 100% of symptomatic periapical le-
sions showed the presence of an HCMV transcript. The 
fact that HCMV was detected as a single infection in 24% 
of all the periapical lesions while no lesions had EBV 
monoinfection shows that the HCMV endodontic patho-
gen is perhaps more important. A study by Sabeti and 
Slots  [24] described only one periapical lesion showing 
EBV monoinfection, while Sabeti et al.  [25] found HCMV 
active infection in 92% and EBV infection in 62% of 
symptomatic periapical lesions. Approximately the same 
ratio of these two viruses was found by Yildirim et al.  [26] , 
who examined the presence of herpesvirus in periapical 
lesions of deciduous teeth. Their results show that HCMV 
was present in 58% of the cases, while EBV was present in 
62% of periapical lesions. However, in the study of Herná-
di et al.  [10] , EBV was the predominant pathogen. The 
authors showed that 72.5% of periapical lesions had EBV, 
and HCMV was reported in only 10% of the cases. Ac-
cording to Verdugo et al.  [27] , the low HCMV prevalence 
in their study could be partly explained by the fact that 
study patients had no active periodontal disease and were 
following maintenance protocols.
 The present study demonstrated a significantly higher 
frequency of HCMV infection in symptomatic compared 
to asymptomatic lesions. Similarly, the occurrence of 
EBV infection was observed in symptomatic periapical 
lesions, whereas none of the asymptomatic lesions showed 
the presence of the EBV genome. Regarding the size of the 
lesions, herpesvirus infection was detected in both large 
symptomatic and large asymptomatic lesions. These re-
sults are consistent with the results of other authors who 
found that the incidence of herpesvirus was more com-
mon in symptomatic and large lesions, where the pre-
dominant pathogen was HCMV  [19, 24, 25, 28] . A strong 
statistical correlation was identified between HCMV and 
EBV productive infection in symptomatic periapical le-
sions in the study by Slots et al.  [19] . According to them, 
the reactivation of latent herpesvirus is involved in the 
maintenance of pathological processes in some types of 
symptomatic periapical disease.
 The occurrence of dual HCMV/EBV infection in some 
samples was an important result of this study. The analy-
sis showed that all lesions with dual infections were symp-
tomatic: 9 large and 1 small. These results are consistent 
with the results of Sabeti et al.  [29] who have shown the 
combined findings of HCMV/EBV productive infection 
in all five examined periapical lesions. The lesions were 
relatively large, 8 × 12 mm or more in radiographic size. 
Predominance of HCMV/EBV genome was previously 
detected in symptomatic periapical lesions, 5 × 7 mm or 
more in diameter  [25] . HCMV and EBV may have a 
pathogenic role in severe cases of endodontic diseases. 
Detection of HCMV/EBV dual infection in 76% of symp-
tomatic periapical lesions indicates the importance of the 
herpesvirus interactions in endodontic infections  [19] . 
HCMV reactivation has the potential to transactivate 
EBV and thus create increased pathogenicity of its mech-
anism  [30] . HCMV/EBV dual infection can cause the de-
velopment of severe pathoses, as inferred from nonoral 
diseases, oral ulcers and marginal periodontitis  [31–33] . 
HCMV infects mainly macrophages and T lymphocytes, 
whereas EBV infects B lymphocytes and tonsillar epithe-
lial cells  [9] . High levels of inflammatory cells that have a 
latent herpesvirus, in combination with compromised 
host response in periapical lesions, may create favorable 
conditions for its reactivation  [29] . The cumulative effect 
of endodontic bacteria, herpesviruses and immune-me-
diated tissue destruction, all with the general weakening 
of the host defense, establishes a vicious cycle and makes 
periapical disease much more aggressive.
 Verdugo et al.  [34] examined specific herpesviral-bac-
terial coinfection in established peri-implantitis lesions. 
The higher EBV prevalence in peri-implantitis lesions 
versus saliva or healthy implant sites underscores the po-
tential viral etiological importance. According to that, 
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EBV may be a likely candidate in the etiopathogenesis of 
peri-implant disease.
 Sabeti et al.  [29] examined the role of HCMV and EBV 
in the etiology and pathogenesis of symptomatic periapi-
cal lesions of intact teeth. Since the presence of herpesvi-
ruses in periapical lesions was shown, the authors con-
cluded that HCMV probably did not originate from the 
mouth. According to a study by Rosaline et al.  [35] , 
HCMV, EBV and HSV were not present in the pulp tissue 
of teeth with irreversible pulpitis. This can mean that her-
pesviruses in periapical lesions, detected in a number of 
studies, do not reach the periapical tissues from the oral 
cavity through the pulp.
 The study by Andric et al.  [7] showed the presence of 
HCMV in the walls of odontogenic cysts, periapical cysts 
and odontogenic keratocysts, and more than 50% of
HCMV-positive odontogenic cysts in their study had a 
relatively high frequency of virus detection. Bearing in 
mind the etiology and primary pathogenic differences be-
tween periapical cysts and odontogenic keratocysts, near-
ly the same frequency of HCMV detection in both types 
of cysts was a significant result of this study. A similar 
percentage of HCMV-positive periapical cysts and odon-
togenic keratocysts suggests that HCMV probably does 
not play a significant role in the etiology of these cysts, but 
does affect their behavior during inflammation. Since it 
has been proven that peripheral monocytes and macro-
phages are the main latent HCMV infection site, and mac-
rophages represent a significant part of the inflammatory 
cell infiltrate in periapical lesions, it can be assumed that 
the presence of HCMV in a cystic wall is the result of its 
infected macrophage infiltration. HCMV was detected 
more frequently in the samples collected from the cysts of 
patients who reported previous episodes of infection.
 Since the monocytes and lymphocytes are migrating in 
the periapical sites as the first line of defense, there is a 
possibility that potentially infected B lymphocytes arrive 
into this region. Latently infected B cells can occasionally 
be stimulated to reactivate EBV. This produces a virus 
that can reinfect new B cells and epithelial cells, becoming 
a source of viral transmission. Reactivation could occur 
when latently infected B cells respond to unrelated infec-
tions  [36] . Waldeyer’s tonsillar ring as EBV’s main reser-
voir can potentially shed virions into saliva and the blood-
stream at a continuous pace in healthy carriers. Saliva 
EBV levels can be replaced in as little as 2 min and could 
act as a fine vehicle to transport virus and other pathogens 
to different locations in the oral cavity  [9] .
 PCR detection of herpesvirus has some limitations 
that must be taken into account when discussing the re-
sults of this study. The high sensitivity of PCR can be 
misleading when it comes to the diagnosis of clinically 
significant herpesvirus infections. PCR detection of ac-
tive viral replication becomes a possible problem for de-
tection of latently infected periapical area. These findings 
may reflect only the transient differentiation of mono-
cytes circulating in peripheral macrophages, a process 
which initiates the reactivation of latent viruses and 
which can be expected in the exacerbation of inflamma-
tory response  [7] . As this study has identified the active 
herpesvirus infection, it is not known whether the PCR-
negative periapical areas contain viruses in the latent 
stage.
 The fact that it is still not clear whether the activation 
of the herpesvirus is the cause or if it occurs secondary to 
acute inflammation makes this an important research 
goal. Most likely, there is a two-way interaction between 
the virus and acute inflammation. With the active herpes-
virus infection there is a possibility of inducing the pro-
duction of inflammatory mediators of inflammation, 
which have the potential for propagation of inflammation 
and further activation of the virus. Changes between pro-
longed periods of herpesvirus latency broken by periods 
of activation may partially explain sudden and sometimes 
symptomatic episodes of periapical disease. Frequent re-
activation of periapical herpesvirus can accelerate the de-
velopment of periapical defects, while the absence of her-
pesvirus infection or virus reactivation may be the reason 
why some periapical lesions remain clinically stable for a 
longer period of time  [29] .
 Based on numerous studies that have analyzed the re-
lationship between the detection of herpesvirus in peri-
apical lesions and clinical characteristics of apical peri-
odontitis, different hypotheses have been made about 
their role in the pathogenesis of these chronic processes 
 [15] . The findings of Slots et al.  [37] showed that herpes-
viruses are involved in the pathogenesis of apical peri-
odontitis as a direct result of viral infection or virally in-
duced irregularities of the local host defense which favors 
the growth of bacteria. However, the interpretation of 
Ferreira et al.  [38, 39] suggests that the occurrence of her-
pesvirus may be just an epiphenomenon of bacterial in-
fection that causes inflammation of periapical tissue with 
a consequent influx of virally infected inflammatory cells 
in the periapical region.
 Since the results of several studies indicate that the 
etiopathogenesis of periapical lesions includes herpesvi-
rus, Slots et al.  [19, 37] argue that new directions for api-
cal periodontitis prevention and treatment should focus 
on the control of viral pathogens. It is possible to achieve 
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this effect by using systemic antiviral therapy. A study of 
Sunde et al.  [40] suggested that virus screening and sub-
sequent antiviral therapy may be useful as an adjunct to 
conventional periodontal therapy. The use of strong local 
antiviral root canal irrigants, sodium hypochlorite and 
iodine, may also be helpful in endodontic treatment of 
periapical pathoses.
 Detection of HCMV and EBV in the samples of peri-
apical lesions suggests an important role of herpesviruses 
in periapical tissue destruction. HCMV infections were 
more frequent in symptomatic lesions compared to
asymptomatic lesions. The incidence was higher in large 
symptomatic lesions. EBV infection has occurred only in 
symptomatic lesions, in most cases in large lesions, while 
the dual HCMV/EBV infection has occurred only in 
symptomatic lesions.
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